Prudential Financial Inc. lifted its stake in UnitedHealth Group Inc (NYSE:UNH) by 6.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,560,731 shares of the healthcare conglomerate’s stock after purchasing an additional 146,274 shares during the period. UnitedHealth Group makes up 0.7% of Prudential Financial Inc.’s investment portfolio, making the stock its 18th largest holding. Prudential Financial Inc. owned 0.26% of UnitedHealth Group worth $501,520,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. Capital International Investors lifted its stake in shares of UnitedHealth Group by 399.3% in the third quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock valued at $809,370,000 after purchasing an additional 3,304,902 shares during the period. Jennison Associates LLC lifted its stake in shares of UnitedHealth Group by 146.0% in the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock valued at $1,085,396,000 after purchasing an additional 3,289,470 shares during the period. Janus Henderson Group PLC lifted its stake in shares of UnitedHealth Group by 1,820.1% in the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after purchasing an additional 2,264,242 shares during the period. Vanguard Group Inc. lifted its stake in shares of UnitedHealth Group by 2.5% in the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after purchasing an additional 1,588,516 shares during the period. Finally, Parametric Portfolio Associates LLC raised its position in UnitedHealth Group by 77.3% during the second quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock worth $664,570,000 after acquiring an additional 1,562,661 shares during the last quarter. Hedge funds and other institutional investors own 86.00% of the company’s stock.
In other news, Director Michele J. Hooper sold 10,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $237.76, for a total transaction of $2,377,600.00. Following the completion of the sale, the director now directly owns 37,284 shares in the company, valued at $8,864,643.84. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the sale, the director now owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 53,396 shares of company stock valued at $12,262,067. Insiders own 0.89% of the company’s stock.
A number of equities analysts have issued reports on UNH shares. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price for the company in a research report on Saturday, January 20th. Goldman Sachs Group started coverage on shares of UnitedHealth Group in a research report on Wednesday, January 3rd. They set a “buy” rating and a $269.00 target price for the company. Morgan Stanley lifted their target price on shares of UnitedHealth Group from $215.00 to $235.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 18th. Credit Suisse Group lifted their target price on shares of UnitedHealth Group from $252.00 to $260.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 17th. Finally, Bank of America lifted their target price on shares of UnitedHealth Group from $230.00 to $240.00 and gave the stock a “buy” rating in a research report on Wednesday, October 18th. Two equities research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $243.22.
Shares of UnitedHealth Group Inc (UNH) opened at $225.69 on Tuesday. The company has a market cap of $218,710.00, a PE ratio of 21.07, a PEG ratio of 1.29 and a beta of 0.70. UnitedHealth Group Inc has a twelve month low of $156.49 and a twelve month high of $250.79. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. The business had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.11 earnings per share. research analysts predict that UnitedHealth Group Inc will post 12.51 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: This piece of content was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/13/unitedhealth-group-inc-unh-position-increased-by-prudential-financial-inc.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.